Recently acquired hepatitis C infection: insights from virological, therapeutic and epidemiological studies

最近获得的丙型肝炎感染：病毒学、治疗和流行病学研究的见解

• 批准号: nhmrc : 1051859
• 负责人: A/Pr Gail Matthews
• 金额: $ 27.69万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Career Development Fellowships
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/recently-acquired-hepatitis-epidemiological-studies/112243
• 关键词: Recently; acquired; hepatitis; infection; insights

Every year around 10,000 new cases of hepatitis C (HCV) infection occur within Australia, most of which are undiagnosed. Reasons for this include a lack of public awareness about the benefits of treatment at this stage. As new antiviral agents become available it is likely that therapy for recent HCV will become even easier and more successful. The aim of this research is to explore HCV transmission patterns, treatment strategies and long term health outcomes in people with recent HCV.

澳大利亚每年约有10，000例新的丙型肝炎（HCV）感染病例，其中大多数未被诊断。其原因包括公众对现阶段治疗的好处缺乏认识。随着新的抗病毒药物的出现，近期HCV的治疗可能会变得更加容易和成功。本研究的目的是探讨HCV的传播模式，治疗策略和长期的健康结果在最近的HCV感染者。